How many copies of GSTM1 and GSTT1 are associated with head and neck cancer risk?-Reference-Cited by-同舟云学术

How many copies of GSTM1 and GSTT1 are associated with head and neck cancer risk?

Published:2019-01-01 Issue:3 Volume:24 Page:262-267
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Firigato Isabela¹^ORCID,de Toledo Gonçalves Fernanda¹^ORCID,De Antonio Juliana¹^ORCID,Alberto Curioni Otávio²^ORCID,Rocha Silva Mariana¹^ORCID,Jorge Fígaro Gattás Gilka¹^ORCID

Affiliation:

1. Departamento de Medicina Legal, Etica Medica, Medicina Social e do Trabalho, Instituto Oscar Freire, Faculdade de Medicina da Universidade de Sao Paulo (FMUSP), Sao Paulo, Brazil;

2. Department of Head and Neck Surgery and Otorhinolaryngology, Hospital Heliopolis, Sao Paulo, Brazil

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo.

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2018.1556337

Reference50 articles.

1. Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases

2. Implications of gene copy-number variation in health and diseases

3. Association of glutathione S-transferase GSTM1 and GSTT1 deletion polymorphisms with obesity and their relationship with body mass index, lipoprotein and hypertension among young age Saudis

4. Replication stress and mechanisms of CNV formation

5. Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutathione S-transferase theta 1 (GSTT1) deletion polymorphism and susceptibility to head and neck carcinoma: a systematic review with five analyses;BMC Cancer;2024-07-22

2. Discovery of a novel pyroptosis inhibitor acting though modulating glutathionylation to suppress NLRP3-related signal pathway;International Immunopharmacology;2024-01

3. Role of GSTM1 in Hypertension, CKD, and Related Diseases across the Life Span;Kidney360;2022-12